CAMK2G and neoplasm: This review therefore focuses on the emerging WNT11/CAMKII axis as a newly identified immune resistance pathway in liver metastasis, and discusses its mechanistic roles, clinical implications, and therapeutic potential in reshaping the metastatic tumor microenvironment.